JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M408510200 on August 2, 2004

J. Biol. Chem., Vol. 279, Issue 42, 43560-43567, October 15, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/42/43560    most recent
M408510200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lyon, M.
Right arrow Articles by Gallagher, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lyon, M.
Right arrow Articles by Gallagher, J. T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Interactions of Hepatocyte Growth Factor/Scatter Factor and Its NK1 and NK2 Variants with Glycosaminoglycans Using a Modified Gel Mobility Shift Assay

ELUCIDATION OF THE MINIMAL SIZE OF BINDING AND ACTIVATORY OLIGOSACCHARIDES*

Malcolm Lyon{ddagger}§, Jon A. Deakin{ddagger}§, Daniel Lietha||, Ermanno Gherardi||**, and John T. Gallagher{ddagger}§

From the {ddagger}Cancer Research UK and the Department of Medical Oncology, University of Manchester, Christie Hospital National Health Service Trust, Wilmslow Road, Manchester M20 4BX and the ||Growth Factors Group, Medical Research Council Centre, Hills Road, Cambridge CB2 2QH, United Kingdom

Full-length hepatocyte growth factor/scatter factor interacts with both heparan and dermatan sulfates and is critically dependent upon them as cofactors for activation of the tyrosine kinase receptor Met. Two C-terminally truncated variants (NK1 and NK2) of this growth factor also occur naturally. Their glycosaminoglycan binding properties are not clear. We have undertaken a comparative study of the heparan/dermatan sulfate binding characteristics of all three proteins. This has entailed the development of a modified gel mobility shift assay, utilizing fluorescence end-tagged oligosaccharides, that is also widely applicable to the analysis of many glycosaminoglycan-protein interactions. Using this we have shown that all three hepatocyte growth factor/scatter factor variants share identical heparan/dermatan sulfate binding properties and that both glycosaminoglycans occupy the same binding site. The minimal size of the oligosaccharide that binds with high affinity in all cases is a tetrasaccharide from heparan sulfate but a hexasaccharide from dermatan sulfate. These findings demonstrate that functional glycosaminoglycan binding is restricted to a binding site situated solely within the small N-terminal domain. The same minimal size fractions are also able to promote hepatocyte growth factor/scatter factor-mediated activation of Met and consequent downstream signaling in the glycosaminoglycan-deficient Chinese hamster ovary pgsA-745 cells. A covalent complex of heparan sulfate tetrasaccharide with monovalent growth factor is also active. The binding and activity of tetrasaccharides put constraints upon the possible interactions and molecular geometry within the ternary signaling complex.


Received for publication, July 27, 2004

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Supported by a Programme Grant from Cancer Research UK.

** Supported by Programme Grant G9704528 from the Medical Research Council.

To whom correspondence should be addressed: Dept. of Medical Oncology, Christie CRUK Research Centre, Christie Hospital NHS Trust, Wilmslow Rd., Manchester M20 4BX, United Kingdom. Tel.: 44-161-446-3202; Fax: 44-161-446-3269; E-mail: MLyon{at}picr.man.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Q. Schmidt, A. P. Herbert, D. Kavanagh, C. Gandy, C. J. Fenton, B. S. Blaum, M. Lyon, D. Uhrin, and P. N. Barlow
A New Map of Glycosaminoglycan and C3b Binding Sites on Factor H
J. Immunol., August 15, 2008; 181(4): 2610 - 2619.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
J. A Deakin and M. Lyon
A simplified and sensitive fluorescent method for disaccharide analysis of both heparan sulfate and chondroitin/dermatan sulfates from biological samples
Glycobiology, June 1, 2008; 18(6): 483 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. R. Catlow, J. A. Deakin, Z. Wei, M. Delehedde, D. G. Fernig, E. Gherardi, J. T. Gallagher, M. S. G. Pavao, and M. Lyon
Interactions of Hepatocyte Growth Factor/Scatter Factor with Various Glycosaminoglycans Reveal an Important Interplay between the Presence of Iduronate and Sulfate Density
J. Biol. Chem., February 29, 2008; 283(9): 5235 - 5248.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
W. D. Tolbert, J. Daugherty, C. Gao, Q. Xie, C. Miranti, E. Gherardi, G. Vande Woude, and H. E. Xu
A mechanistic basis for converting a receptor tyrosine kinase agonist to an antagonist
PNAS, September 11, 2007; 104(37): 14592 - 14597.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Herbert, J. A. Deakin, C. Q. Schmidt, B. S. Blaum, C. Egan, V. P. Ferreira, M. K. Pangburn, M. Lyon, D. Uhrin, and P. N. Barlow
Structure Shows That a Glycosaminoglycan and Protein Recognition Site in Factor H Is Perturbed by Age-related Macular Degeneration-linked Single Nucleotide Polymorphism
J. Biol. Chem., June 29, 2007; 282(26): 18960 - 18968.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
R. Sakiyama, K. Fukuta, K. Matsumoto, M. Furukawa, Y. Takahashi, and T. Nakamura
Stimulation of Hepatocyte Growth Factor Production by Heparin-derived Oligosaccharides
J. Biochem., May 1, 2007; 141(5): 653 - 660.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Herbert, D. Uhrin, M. Lyon, M. K. Pangburn, and P. N. Barlow
Disease-associated Sequence Variations Congregate in a Polyanion Recognition Patch on Human Factor H Revealed in Three-dimensional Structure
J. Biol. Chem., June 16, 2006; 281(24): 16512 - 16520.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Robinson, N. J. Harmer, S. J. Goodger, T. L. Blundell, and J. T. Gallagher
Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1{middle dot}FGFR2c{middle dot}Heparin Ternary Complexes
J. Biol. Chem., December 23, 2005; 280(51): 42274 - 42282.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
N. T. Seyfried, C. D. Blundell, A. J. Day, and A. Almond
Preparation and application of biologically active fluorescent hyaluronan oligosaccharides
Glycobiology, March 1, 2005; 15(3): 303 - 312.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.